Skip to main content

DEUTSCHE BANK AG\

Bank

Position in KROS — Keros Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in KROS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$500,781
-$59,664 QoQ
Shares Held
46,802
-7.8% QoQ
Ownership
0.236%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. KROS ranks #181 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $500,781 46,802
2026-03-31 $560,445 50,765
2025-12-31 $3,975,921 195,281
2025-09-30 $367,957 23,259
2025-06-30 $2,825,353 211,637
2025-03-31 $233,982 22,962
2024-12-31 $426,729 26,957
2024-09-30 $1,074,875 18,510
2024-06-30 $5,671,963 124,113
2024-03-31 $8,213,566 124,072
2023-12-31 $14,245,052 358,276
2023-09-30 $400,795 12,572
2023-06-30 $3,330,559 82,891
2023-03-31 $3,731,808 87,396
2022-12-31 $549,828 11,450
2022-09-30 $302,614 8,044
2022-06-30 $283,897 10,275
2022-03-31 $551,412 10,140
2021-12-31 $652,152 11,146
2021-09-30 $426,337 10,777
2021-06-30 $469,887 11,064
2021-03-31 $594,079 9,652
2020-12-31 $736,718 10,444
2020-09-30 $148,571 3,852
2020-06-30 $131,884 3,516